Vnebol'nichnaya pnevmoniya, «ne otvechayushchaya» na antibakterial'nuyu terapiyu


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article discusses the problems associated with community-acquired pneumonia (CAP) «not responding» to the antibacterial therapy. Information regarding the prevalence, prognosis, reasons of therapeutic inefficiency, risk factors, and tactics of management of patients with CAP is presented.

Full Text

Restricted Access

About the authors

A. I Sinopal'nikov

E. A Styrt

References

  1. Ewig S., Woodhead M., Torres A. Towards a sensible comprehension of severe community-acquired pneumonia. Intensive Care Med. 2011; 37: 214-23.
  2. Menendez R., Torres A. Treatment failure in community-acquired pneumonia. Chest. 2007; 132: 1348-55.
  3. Low D.E., Mazulli T., Marrie T.J. Progressive and nonresolving pneumonia. Curr. Opin. Pulm. Med 2005; 11: 247-52.
  4. Roson B., Carratala J., Fernandez-Sabe N., et al. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch. Intern. Med. 2004; 164: 502-08.
  5. Mandell L.A., Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America / American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007; 44: S27-72.
  6. Montravers P., Fagon J.Y., Chastre J., et al. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am. Rev. Respir. Dis. 1993; 147: 38-44.
  7. Kheir F., Hamdi T., Khayr W., et al. Nonresolving pneumonia. Am. J. Ther. 2011; 18: 77-9.
  8. Aliberti S., Amir A., Peyrani P., et al. Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia. Chest. 2008; 134: 955-62.
  9. Aliberti S., Blasi F. Clinical stability versus clinical failure in patients with community-acquired pneumonia. Semin. Respir. Crit. Care Med. 2012; 33: 284-91.
  10. Arancibia F., Ewig S., Martinez J.A., et al. Antimicrobial treatment failures in patients with community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 2000; 162: 154-60.
  11. Menendez R., Torres A., Zalacain R., et al. Risk factors of treatment failure in community-acquired pneumonia: implications for disease outcome. Thorax. 2004; 59: 960-65.
  12. Menendez R., Torres A., Reyes S., et al. Initial management of pneumonia and sepsis: factors associated with improved outcome. Eur. Respir. J. 2012; 39: 156-62.
  13. Arancibia F., Ewig S., Martinez J.A., et al. Antimicrobial treatment failures in patients with community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 2000; 162: 154-60.
  14. Celis M.R., Torres A., Zalacain R., et al. Working group for the study, diagnosis and treatment of CAP in Spain (NACE). Diagnostic methods and treatment of community-acquired pneumonia in Spain: NACE study. Med. Clin. (Barc). 2002; 119: 321-26.
  15. Sialer S., Liapikou A., Torres A. What is the best approach to the nonresponding patient with community-acquired pneumonia? Infect. Dis. Clin. N. Am. 2013; 27: 189-203.
  16. Woods C., Colice G. Methicillin-resistant Staphylococcus aureus pneumonia in adults. Expert. Rev. Respir. Med. 2014; 17: 1-11.
  17. Franquet T. Imaging of pneumonia: trends and algorithms. Eur. Respir. J. 2001; 18: 196-208.
  18. Washington L., Palacio D. Imaging of bacterial pulmonary infection in the immunocompetent patient. Semin. Roentgenol. 2007; 42: 122-45.
  19. Sanyal S., Smith P.R., Saha A.C., et al. Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 1999; 160: 346-48.
  20. Menendez R., Torres A., Zalacain R., et al. Guidelines for the treatment of community-acquired pneumonia. Predictors of adherence and outcome. Am. J. Respir. Crit. Care Med. 2005; 172: 757-62.
  21. Aliberti S., Di Pasquale M., Zanaboni A.M., et al. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin. Infect. Dis. 2012; 54: 470-78.
  22. Shorr A.F., Zilberberg M.D., Micek S.T., et al. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch. Intern. Med. 2008; 168: 2205-10.
  23. Kirtland S., Witerbauer R. Slowly resolving, chronic, and recurrent pneumonia. Clin. Chest. Med. 1991; 12: 303-18.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies